| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/26/2006 | CN1763174A Culture and collection of dermatophagoides pteronyssinus and method for preparing its allergen diagnosis and treatment preparation |
| 04/26/2006 | CN1763097A Polypeptide variants with altered effector function |
| 04/26/2006 | CN1763088A Protein related to human hair and tooth development amd its coding gene |
| 04/26/2006 | CN1762492A CD40 binding molecules and CTL peptides uses in pharmic composition for treating tumors |
| 04/26/2006 | CN1762193A Method for producing black fungus |
| 04/26/2006 | CN1253579C Preparation method for improving output of gentamycin |
| 04/26/2006 | CN1253575C Methods for producing a polypeptide using a consensus translational initiator sequence |
| 04/26/2006 | CN1253574C A fungus wherein areA gene has been modified and areA gene from aspergillus oryzae |
| 04/26/2006 | CN1253573C Transgenic amorpha-4,11-diene synthesis |
| 04/26/2006 | CN1253570C Isolated DNA sequence which can serve as terminator region in a chimeric gene capable of being used for the transformation of plants |
| 04/26/2006 | CN1253554C acidophilic bacteria strain with nitrile hydrolase activity |
| 04/26/2006 | CN1253553C Ceramide bacillus and method for production of glycoprotein analog biological flocculant using same |
| 04/26/2006 | CN1253552C Streptomyces griseoalbus |
| 04/26/2006 | CN1253551C Genetically modified tumor-targeted bacteria with reduced virulence |
| 04/26/2006 | CN1253550C Aspergillus flavus and process for producing calcium tartaric using the same |
| 04/26/2006 | CN1253470C Treatment of inflammatory disease |
| 04/26/2006 | CN1253072C Production method for Pleurotus tuber- regium (Fr.)Sing and relevant culture medium thereof |
| 04/25/2006 | US7034141 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 04/25/2006 | US7034140 Isolated from Rhodococcus; steroids; carotenoids |
| 04/25/2006 | US7034137 Isolated mammalian membrane protein genes; related reagents |
| 04/25/2006 | US7034136 Nucleic acids encoding PRO1159 polypeptides |
| 04/25/2006 | US7034125 Comprises neurotransmitter transport protein for monitoring and evaluating modulators of neuronal signaling; diagnosis and treatment of schizophrenia, epilepsy, depression, learning and neurodegenerative disorders |
| 04/25/2006 | US7034119 Method for recombinant production of polypeptides |
| 04/25/2006 | US7034108 Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof |
| 04/25/2006 | US7033993 Polypeptide for use in biological pest control |
| 04/25/2006 | US7033981 Alkaline cellulase variants |
| 04/25/2006 | US7033833 Polynucleotides encoding carnation senescense-induced EIF-5A |
| 04/25/2006 | US7033827 Prostate-specific polynucleotide compositions |
| 04/25/2006 | US7033824 Plasmids for use as tools in genetic engineering |
| 04/25/2006 | US7033823 Cell-cultivating device |
| 04/25/2006 | US7033818 Genetically engineered polyketide synthase for use in generation of polyketides |
| 04/25/2006 | US7033817 Proteases from gram positive organisms |
| 04/25/2006 | US7033816 Activators of cyclin-dependent kinases |
| 04/25/2006 | US7033815 Biosynthesis of S-adenosylmethionine in a recombinant yeast strain |
| 04/25/2006 | US7033814 Methods for preparing yeast with improved biotin productivity using integrating plasmids encoding biotin synthase |
| 04/25/2006 | US7033811 Polypeptides having xyloglucanase activity and nucleic acids encoding same |
| 04/25/2006 | US7033810 Sitosterolemia susceptibility gene (SSG): compositions and methods of use |
| 04/25/2006 | US7033809 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/25/2006 | US7033808 Carbonyl reductase, gene thereof and method of using the same |
| 04/25/2006 | US7033807 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 04/25/2006 | US7033806 HY2 family of bilin reductases |
| 04/25/2006 | US7033805 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase. |
| 04/25/2006 | US7033801 hybridizing linear strands containing poxyvirus topoisomerase recognition regions |
| 04/25/2006 | US7033796 cloned from cDNA library of human liver carcinoma cell line using PCR amplification; host cells |
| 04/25/2006 | US7033795 FabK variant |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033793 Genes and proteins can be used in making transgenic animals and in assays designed to determine the likelihood of an individual developing cardiomyopathy |
| 04/25/2006 | US7033788 Saxatilin isolated via gel fitration of venom from vipers, then performing high performance liquid chromatography; for use as anti-platelet aggregation agents and antitumor agents |
| 04/25/2006 | US7033786 Identification and isolation of DNA and recombinant production of polypeptides |
| 04/25/2006 | US7033785 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders |
| 04/25/2006 | US7033781 gene knockout; for production of transgenic microbes, plants, progenitor cells |
| 04/25/2006 | US7033779 Method for preparing steroids modified by yeast fermentation |
| 04/25/2006 | US7033774 Comprises immunoglobulin for detection of drugs and/or natural peptide hormones used for enhancing athletic performance and in humans and animals |
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033768 Reverse two-hybrid systems |
| 04/25/2006 | US7033596 Transformant for screening of inhibitors for human immunodeficiency virus |
| 04/25/2006 | US7033592 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection |
| 04/25/2006 | US7033586 Insecticidal Paecilomyces tenuipes strain FERM BP-7861 |
| 04/25/2006 | US7033584 Growing Thraustochytrium, Schizochytrium, and/or mixtures in a culture medium containing a non-chloride sodium salt, e.g., sodium sulfate; microfloral biomass; aquaculture of larval shrimp, rotifers, molluscs; extruded food with flaxseed meal |
| 04/20/2006 | WO2006041280A1 Novel regulation protein |
| 04/20/2006 | WO2006041226A1 Improved hydroxynitrile lyase |
| 04/20/2006 | WO2006041143A1 Dna encoding novel enzyme having d-serine synthase activity, method of producing the enzyme and method of producing d-serine by using the same |
| 04/20/2006 | WO2006041096A1 Integrase originating in staphycoloccus aureus bacteriophage φmr11 and site-specific gene recombination method using recognition sequence thereof |
| 04/20/2006 | WO2006040955A1 Process for producing cohesive alcohol fermentation yeast and cohesive alcohol fermentation yeast |
| 04/20/2006 | WO2006040257A1 Lyophilised lactic acid bacteria and bifidobacteria products with a high degree of dispersibility |
| 04/20/2006 | WO2005047314A3 Fgf-beta binding and supported peptides |
| 04/20/2006 | WO2005040751A3 Decontamination and concentration kit for mycobacteria |
| 04/20/2006 | WO2004078935A3 Removal of plastid sequences by transiently expressed site-specific recombinases |
| 04/20/2006 | WO2004044164A3 Method for identifying risk of melanoma and treatments thereof |
| 04/20/2006 | WO2003066871A3 Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds |
| 04/20/2006 | WO2003014312A3 Alteration of acyltransferase domain substrate specificity |
| 04/20/2006 | US20060085873 Plasmid vector for expression of hepatitis B virus genes in plants, transgenic cell lines for the genes, and the use thereof in manufacture |
| 04/20/2006 | US20060085870 Plant fungicide, pesticides, insecticides; insertion protease detectors; corn |
| 04/20/2006 | US20060084792 Versatile platform for nanotechnology based on circular permutations of chaperonin protein |
| 04/20/2006 | US20060084600 Human homologues of fused gene |
| 04/20/2006 | US20060084574 Fungal isolates and biological control compositions for the control of weeds |
| 04/20/2006 | US20060084165 can be miniaturized using a laser diode, a DNA purification can be directly performed after a disruption of cells, and a solution containing DNA can be transferred to a subsequent step after cell debris and beads to which inhibitors of a subsequent reaction are attached are removed with an electromagnet |
| 04/20/2006 | US20060084164 Bacteria, yeasts or filamentous fungi, producing a fusion protein containing a hydrophobin fused to a protein, an enzyme or part of an enzyme with enzymatic activity, wherein said hydrophobin or hydrophobin-like protein has an ability to partition in aqueous two-phase systems (ATPS) |
| 04/20/2006 | US20060084158 Treatment of biological material containing living cells using a plasma generated by a gas discharge |
| 04/20/2006 | US20060084157 Hydrogen production |
| 04/20/2006 | US20060084155 transferase for producing 4-hydroxybutyryl-Co A (4HB) containing polyhydroxyalkanoate (PHAs) from cheap carbon sources such as sugars and fatty acids |
| 04/20/2006 | US20060084152 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 04/20/2006 | US20060084151 Culturing a microorganism in a liquid medium within a pH range which is controlled so that L-glutamic acid precipitates; adding L-lysine to the medium once the culture solution is saturated or over-saturated with L-glutamic acid; collecting alpha -form crystals of L-glutamic acid |
| 04/20/2006 | US20060084148 April-a novel protein with growth effects |
| 04/20/2006 | US20060084147 Apo-2 receptor |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084141 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 04/20/2006 | US20060083753 Fusobacterium polypeptides and methods of use |
| 04/20/2006 | US20060083752 Novel compounds |
| 04/20/2006 | US20060083750 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| 04/20/2006 | US20060083746 Receptor for B. anthracis toxin |
| 04/20/2006 | US20060083726 Method for controlling insects of the order diptera using a Bacillus thuringiensis strain |
| 04/20/2006 | US20060083723 Dietary supplement, food, healthy food, medical food, topic dermatitis |
| 04/20/2006 | US20060083716 Composition for delivering an agent to a target cell and uses thereof |
| 04/20/2006 | US20060081532 Nitrosomonas and Nitrobacter for oxidizing ammonia and nitrite; aquaculture; use in shrimp ponds to increase yield and size |
| 04/20/2006 | DE19754938B4 TGC-Verfahren zur Induktion einer zielgerichteten, somatischen Transgenität TGC method for inducing a targeted somatic transgenic |
| 04/20/2006 | CA2583668A1 Synbiotics |
| 04/20/2006 | CA2583449A1 A method of cultivating animals to develop a desired color and to increase their rate of growth |
| 04/20/2006 | CA2580421A1 Lyophilised lactic acid bacteria and bifidobacteria products with a high degree of dispersibility |
| 04/20/2006 | CA2579161A1 Novel regulation protein |